Farther Finance Advisors’s Lexeo Therapeutics LXEO Stock Holding History

Farther Finance Advisors’s Portfolio LXEO Stock Details LXEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.75K	Buy	812 +653	+411%	+$2.96K	﹤0.01%	5282
2026 Q2	$740	Buy	+159	New	+$860	﹤0.01%	5452
2026 Q1	–	Sell	-57	Closed	-$566	–	5839
2025 Q4	$566	Buy	+57	New	+$520	﹤0.01%	5031

Other funds holding LXEO

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's LXEO Position: Q3 2026 in Review

Farther Finance Advisors increased its Lexeo Therapeutics (LXEO) stake by 411% in Q3 2026, buying an estimated $2.96K and bringing the position to 812 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #5282.

Farther Finance Advisors first reported a position in LXEO in Q4 2025 and has held it in 3 quarters since. 3 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

Farther Finance Advisors held 812 shares of Lexeo Therapeutics worth $2.75K as of Q3 2026.
Farther Finance Advisors bought 653 Lexeo Therapeutics shares in Q3 2026, an estimated $2.96K.
Lexeo Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5282 holding.
Farther Finance Advisors first reported a position in Lexeo Therapeutics in Q4 2025 and has held it in 3 quarters since.
3 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.